Electrophysiological data suggest that an abnormal oscillatory pattern of discharge in cortical and thalamic neurons may be the major mechanism underlying primary generalised epilepsy. No neurochemical or anatomical substrate for this theory has hitherto been demonstrated in humans and the pathophysiology of primary generalised epilepsy remains unknown. By means of PET and the benzodiazepine (BZ) ligand ["C]flumazenil it has been previously shown that the BZ receptor density is reduced in the epileptic foci of patients with partial epilepsy. In the present study the method was further developed and used in a comparative analysis of cortical, cerebeilar, and subcortical BZ receptor binding in patients with primary generalised tonic and clonic seizures (n = 8), and healthy controls (n = 8). Patients with generalised seizures had an increased BZ receptor density in the cerebellar nuclei (p = 0-006) and decreased density in the thalamus (p = 0.003). No significant changes were seen in the cerebral and cerebeliar cortex or in the basal ganglia. The observed alterations suggest that the yamino-butyric acid (GABA)-BZ system may be affected in the cerebello-thalamocortical loop of patients with generalised epilepsy and indicate possible targets for selective pharmacological treatment. (7 Neurol Neurosurg Psychiatry 1994;57:797-804) 
Generalised epilepsy is a common, yet enigmatic disease. Our knowledge about its pathophysiology is based mainly on electrophysiological experiments, the results of which have led to the centrencephalic' and the corticoreticular theories.2 The first attributes generalised epilepsy to pathological changes in the thalamic nuclei, whereas the second postulates that ascending impulses from the thalamus impinge on a diffusely hyperexcitable cortex, inducing the generalised epileptic discharges. Thus in both theories a neuroanatomical substrate is hypothesised (thalamus, cerebral cortex), but no such substrate has hitherto been shown in humans. The major factors underlying the proposed disturbances in the thalamocortical oscillations could be changes in the excitation, inhibition, or synchronisation of the involved neuronal circuits. The major inhibitory neurotransmitter in the human brain is y-aminobutyric acid (GABA). Its action is mediated by the GABAA-benzodiazepine (BZ) receptor complex.
With the PET technique we recently
showed that the measured BZ receptor density was reduced in the epileptic foci of patients with partial epilepsy. 34 In a follow up study on patients with primary generalised epilepsy no similar reductions were demonstrated, but in comparison with patients with partial epilepsy there was a non-significant tendency towards lower mean cortical BZ receptor density. I Thus if cerebellar changes were observed, it would be difficult to decide whether they were related to generalised epilepsy or to a possible phenytoin toxicity. Therefore, for the assessment of possible phenytoin-related changes in the cerebellar BZ receptor binding, nine phenytoin treated patients with partial epilepsy served as a control group supplementary to the healthy subjects.
The patients with partial epilepsy were aged 34 (SD 8) years, had histories of phenytoin treatment, and phenytoin doses that were compatible with those of patients with generalised seizures. Three patients had frontal foci, five temporal, and one had an occipital focus. Four of the foci were left-sided and five right-sided.
The healthy controls consisted of eight male volunteers, aged 30(SD 5) years, with normal physical state, routine laboratory tests, CT scans, and EEGs. They had no hereditary predisposition for epilepsy and no history of benzodiazepine, phenobarbitone, carbamazepine, or phenytoin treatment. They were free from medication for at least 10 weeks before the experiments. The study was approved by the local ethics and radiation safety committees.
EXPERIMENTAL PROCEDURE
The PET studies were performed on a PC 384-7B system (General Electrics, USA), which measures the brain radioactivity in seven 10 mm slices with spatial resolution of 7-6 mm.'2 The attenuation correction was performed with contour finding. '2 The MRT examinations were performed on a 0 5 Tesla Siemens Magnetom instrument with spatial resolution of 1-5 mm and slice thickness of 10 mm. Tl-weighted, T2-weighted and inversion recovery images were obtained for each patient. The spacing between slice centres was 13-5 mm during both CT scans and MRTs to comply with the orientation of the slices of the PET camera. Two scanning series were performed with 6-75 mm axial displacement to obtain more detailed anatomical information. In all tomographic studies a stereotaxic helmet fixation of the head was used.'3 This device made it possible to select comparable imaging planes for the PET scans in all subjects and to avoid artifacts due to head movement. The subjects were positioned so that the cerebellum and the thalamus were optimally disclosed. The patients were examined interictally and at least 32 hours after the last seizure. 
The ratios are based on the uptake images representing average concentration of ["C]flumazenil between 10 and 56 minutes after the high specific activity bolus. The differences are not statistically significant after the Bonferroni correction (p = 0-028 for the thalamus and p = 0-076 for the cerebellar nuclei).
called subtraction images) was obtained. As the computer program allowed only positive values, the subtraction was performed in both directions (controls-patients with generalised epilepsy, and patients with generalised epilepsy-controls). This procedure yielded an overview of the regional increases as well as decreases in the calculated BZ receptor density in the patients with generalised epilepsy. Statistical evaluation was based on individual BMD, values from each investigated region of interest. The subtraction images were, however, important for the visual analysis of possible alterations in BZ receptor density outside the predefined regions of interest.
ANALYSIS OF REGIONAL DIFFERENCES IN BZ RECEPTOR BINDING
The comparisons between patients with generalised epilepsy and controls were performed on regions of interest in the following (tables 1 and 2):
(1) the mesial temporal lobe consisting of amygdala and hippocampus.
(2) the thalamus; due to limited spatial resolution of the camera this region of interest consisted of all the thalamic nuclei including the thalamic reticular nucleus where BZ receptors are sparse.
(3) the caudate + putamen. (4) the cerebellar nuclei (including the dentate and emboliform nuclei-the two nuclei involved in the cerebellocerebral connections).
(5) the quandrangular cerebellar lobe (including the anterior and posterior part).
(6) the semilunar cerebellar lobe (including the superior and inferior part).
(7) the big, multilobar cortical region.4 Extremely small structures, such as the substantia nigra, were not investigated due to the limited spatial resolution of the PET camera.
In the patients with partial epilepsy only the cerebellar regions were analysed. 
Results
The plasma metabolites (47(12)% after 36 minutes) and the elimination T11, (27(8) minutes) in patients with generalised epilepsy were not significantly different from the corresponding indices in the healthy subjects.21
The regional Bm., values from reformatted and original Bma,. images corresponded, which supported the previously reported accuracy of the reformation process.25 No significant asymmetries were found in any of the analysed regions in the three groups.
In relation to the healthy controls, the patients with generalised epilepsy had a high cerebellar nuclei/pons ratio and low thalamus/pons ratio (table 1). The same was valid also for the corresponding regions of interest/white matter ratios ( There were no significant differences in the
regional Bm,, values between patients with more than one seizure monthly (n = 4) and patients with less than one seizure monthly (n = 4) (Mann-Whitney U test). As pointed out in the methods, in patients with partial epilepsy only the cerebellar structures were analysed. These patients showed no significant differences from the controls in any of the cerebellar regions of interest, including both sides (table 2) Sub 2 and Sub 4 was the reverse. In both av and sub images the dentate nuclei and the thalamus were retrieved directly from the atlas program. The reason for the slight asymmetry in the dentate nuclei is that the postmortem brain that the adas program is based on was slightly asymmetrical in the posterior part. As pointed out in the results, no systematic asymmetries were found in the patients or controls. Note that in both B and C the colour code denotes only positive values. Thus in C only the relative increases are shown. Therefore, the subtractions were performed both ways and the decreases as well as increases in BZ-B,,, ofpatients with generalised epilepsy were visualised. The subtraction images (C 1-4) show the numerical (pmollml) differences between the groups. Thus although the numeric differences are lower in the thalamus than in the cortex, the significance level is reached only in the former region as the thalamus has lower BZ receptor density than the cortex. The same is validfor the seemingly increased density in the left quadrangular lobe in the patients (image C2); this difference was not significant. The exactly the same structure, predefined from the computerised atlas, were obtained from each subject. The precision of the reformation process has been evaluated in an earlier study25 and found to be high (SD of about 1 mm for lateral dislocation of the midline structures). Finally, the atlas also enabled construction of averaged and subtraction Bmax images, in which the signal to noise ratio for the analysis of regional differences between two groups was increased. Therefore, the alterations in small structures such as cerebellar nuclei (about 2-3 camera-voxels) could be regarded as reliable.
The most prominent finding in the present study was that the calculated Bmax values were increased in the cerebellar nuclei and decreased in the thalamus of patients with generalised epilepsy. According to the present data and earlier results,'92' these changes can not be ascribed to differences in the pharmacokinetics of ["C]flumazenil between patients and controls. Neither can they be effects of variations in regional cerebral blood flow.3 27 It is unlikely that the differences were caused by a systematic difference in the white matter concentration of ["C]flumazenil as, in relation to the healthy controls, the patients with generalised epilepsy had both regional increases and decreases in the Bmax values. Also, the use of the pons as a reference region did not change the results. Theoretically a major change in the concentration of free + non-specific radioligand in patients with generalised epilepsy could explain the observed differences; it is, however, from the biological point of view, unlikely that the concentration of free --non-specific radioligand in these patients would be increased in the cerebellar nuclei and at the same time be decreased in the thalamus.
Another methodological pitfall to be considered is the possibility of a systematically different adaptation of the anatomical atlas in the axial direction in patients v controls. A displacement of the atlas contours by 6 In the present study, the previously applied pseudoequilibrium method was abandoned because it has been shown that the condition of an absolute equilibrium does not prevail and that the Bmax and Kd estimates are timedependent. '9 20 Therefore, the full time courses of ligand concentration (except the initial 10 minutes) were used both in the target and the reference regions. Use of a reference region to estimate the time course of unbound radioligand implies a simplification that needs a comment. With this procedure, the pool of unbound radioligand serves as input function to the pool of specifically bound radioligand, and a determination of the transport kinetics across the blood brain barrier becomes unnecessary. The drawback is the difficulty in estimating the concentration of unbound ligand in the region with specific binding. Even if the transport of ligand across the blood brain barrier is the same in the reference and target regions the course of the unbound ligand will be different in the two regions. This difference, as well as the blood-flow-related difference in the time course of unbound radioligand in the reference and target regions, is most pronounced during the first minutes after a bolus injection. At a sufficiently long time after the injection, however, the ratio between the concentrations of unbound radioligand in the tissue and the plasma will approach the same volume of distribution whether there is specific binding or not. 28 The data from the initial 10 minutes were therefore always excluded as this is the period of ligand distribution, when the effects of the different kinetics of free ligand in white and grey matter are most pronounced. Also, after the first 10 minutes, the effects of possible differences in the cerebral blood flow between patients and controls are negligible.3
In our earlier papers only data from 15-36 minutes were included. As both the Bmax and the K, estimates decrease with time after a bolus,'920 the Bma, values in the present study are systematically lower, but the Bmax/Kd ratios are about the same. It should, however, be emphasised that the kinetic method, from a theoretical point of view, is considered to be more adequate than the equilibrium method, and that present Bm. values correspond better to the postmortem values. 28 The BZ receptor binding in the cerebellar nuclei has not been evaluated with PET before. The Bmax values in the control subjects, however, were in accordance with human postmortem data. 29 The values in the thalamus and caudate putamen were probably underestimated in the present study and should be interpreted with some caution. One possible reason is that the thalamic regions of interest included all nuclei, even the thalamic reticular nucleus which has few receptors. This was not the case in other reports.2629 Another is that the applied pixel by pixel method is extremely sensitive for positioning errors, which are inevitable even with the helmet fixation of the head.'7 This does not affect large regions of interest, but in small, low density regions that are surrounded with low activity areas both the Bmx and the K& values (but not the Bma,,/Kd ratios) may be systematically underestimated. In the present study, however, the relative differences were more important than the absolute values. Furthermore, the uptake image-based ratios of thalamus and caudate putamen with pons and white matter were in accordance with corresponding values from other studies,2629 and yet differences in the same direction as those based on Bmax images were obtained (tables 1 and 2). Thus it can be concluded that both unquantified (table 1)  and quantified (table 2) values reflect biological changes in patients with generalised epilepsy.
THEORETICAL CONSIDERATIONS
To interpret the present findings some details from previous experiments' 2 3033 should be considered:
The prerequisite for generalised spike-andwave discharges is considered to be an enhancement and synchronisation of the thalamocortical and corticothalamic impulses, volleys.'0 This synchronisation is exerted by recruitment of the cortical GABA intemeurons and the GABA neurons of the thalamic reticular nucleus, the second acting via the GABAA-BZ receptors localised on the thalamic relay cells." Interestingly, the thalamic nuclei involved in generalised seizures,32 are activated by excitatory output of the dentate nuclei in the cerebellum (fig 2) .
The major input to the cerebellar nuclei is inhibitory and derives from the GABAergic Purkinje cells.67 During cortical epileptic activity, an initial enhancement and a subsequent cessation of the Purkinje cell activity (interpreted as a fatigue phenomenon) has been shown." In the same experiment it was also shown that the sudden cessation of Purkinje cell firing precedes an enhancement of cortical epileptic discharges and development of seizures.
The GABA-BZ system thus seems to be involved in the development and maintenance of generalised seizures at several anatomical sites in the brain. The exact mechanisms behind the BZ receptor changes in the present study are, however, unknown and several possible mechanisms might be considered:
( Bm. values in the thalamus could be ascribed to a destruction of the postsynaptic thalamic relay cells. Our patients had moderate seizure frequency, however, and no histories of longlasting seizures or epileptic state. Furthermore, the contours of the thalamus and cerebellar regions of interest derived from the data base fitted well with the contours of corresponding structures in the individual MR images, indicating that patients with generalised epilepsy had no visually detectable atrophies in these regions. Finally, a reduced BZ receptor density was not found in the cerebellar cortex, which would have been expected when considering that the Purkinje cells themselves expose BZ receptors6 7and that the applied method allows detection of such a reduction. '8 Functional disturbances leading to a "vicious circle" In such a circle, an impaired Purkinje cell control over the cerebellar nuclei could lead to an activation of the thalamus, and a facilitation of cortical epileptic discharges leading to a further increased drive of the already exhausted Purkinje cells (fig 2) . This chain of effects could then result in a compensatory increase of BZ receptors in the cerebellar nuclei and a down-regulation/blockade39 of BZ receptors in the thalamus and perhaps also cerebral cortex (table 2) .
The cited alternatives are not mutually exclusive. Additional studies are, however, needed to confirm the findings and evaluate the validity of possible explanations.
To our knowledge this is the first time that a neurochemical-anatomical substrate has been delineated in vivo in human generalised epilepsy. The results seem consistent with the centrencephalic theory of Jasper and Penfield and are supported by experimental data showing reduced BZ binding in the thalamus of Mongolian gerbils.40 There is presently no way, however, of knowing whether the thalamic and cerebellar findings are the main pathological feature, or an effect of a disorder primarily affecting the cerebral cortex but subsequently leading to a Purkinje cell dysfunction and alterations in the cerebellothalamocortical loop, according to the proposed "vicious circle" theory ( fig 2) . This important issue will be considered in future studies.
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